Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-07-19 Sale | 2021-07-21 5:21 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $126.43 | $1,264,348 | 498,558 (Indirect) | View |
2021-06-29 Sale | 2021-06-30 6:41 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 47,536 | $149.49 | $7,106,341 | 1,581,188 (Indirect Direct) | View |
2021-06-28 Sale | 2021-06-30 6:38 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,375 | $152.48 | $4,631,583 | 158,831 (Indirect Direct) | View |
2021-06-28 Purchase | 2021-06-30 5:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 157,895 | $19 | $3,000,005 | 2,097,938 (Indirect) | View |
2021-06-11 Sale | 2021-06-15 4:41 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $126.61 | $1,266,118 | 1,575,335 (Indirect Direct) | View |
2021-03-22 Sale | 2021-03-24 6:00 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,374 | $132.37 | $4,020,667 | 1,585,335 (Indirect Direct) | View |
2021-02-19 Sale | 2021-02-23 4:40 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 171,003 | $149.11 | $25,497,840 | 1,628,724 (Indirect Direct) | View |
2020-12-16 Sale | 2020-12-18 7:12 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $148.95 | $2,234,266 | 3,040,462 (Indirect Direct) | View |
2020-12-10 Sale(A) | 2020-12-17 7:14 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) | View |
2020-12-10 Sale | 2020-12-14 7:11 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) | View |
2020-12-07 Sale | 2020-12-09 7:54 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 171,004 | $154.53 | $26,424,505 | 3,088,462 (Indirect Direct) | View |
2020-11-30 Sale | 2020-12-01 7:13 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 10,393 | $33.15 | $344,513 | 2,138,983 (Indirect Direct) | View |
2020-11-19 Sale | 2020-11-23 4:39 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 130,017 | $33.01 | $4,291,861 | 6,693,509 (Indirect Direct) | View |
2020-11-17 Sale | 2020-11-19 9:19 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 4,730 | $33.05 | $156,349 | 6,808,363 (Indirect Direct) | View |
2020-11-13 Sale | 2020-11-17 7:28 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 4,700 | $33.74 | $158,587 | 6,812,541 (Indirect Direct) | View |
2020-11-12 Sale | 2020-11-13 7:46 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 15,598 | $34.15 | $532,642 | 5,972,906 (Indirect Direct) | View |
2020-11-10 Sale | 2020-11-12 5:38 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 39,583 | $34.11 | $1,350,354 | 7,775,016 (Indirect Direct) | View |
2020-11-06 Sale | 2020-11-10 7:24 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 9,400 | $33.08 | $310,949 | 7,809,983 (Indirect Direct) | View |
2020-11-04 Sale | 2020-11-06 4:49 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 11,348 | $33.14 | $376,127 | 7,818,286 (Indirect Direct) | View |
2020-10-26 Sale | 2020-10-28 5:51 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 8,903 | $33.28 | $296,293 | 7,828,310 (Indirect Direct) | View |
2020-10-15 Sale | 2020-10-20 8:03 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 15,746 | $33.44 | $526,529 | 7,836,175 (Indirect Direct) | View |
2020-10-13 Sale | 2020-10-15 7:26 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 17,240 | $33.3 | $574,015 | 7,850,084 (Indirect Direct) | View |
2020-10-08 Sale | 2020-10-13 7:48 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 22,625 | $33.5 | $757,924 | 7,865,313 (Indirect Direct) | View |
2020-10-06 Sale | 2020-10-08 7:14 pm | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 45,926 | $33.44 | $1,535,732 | 311,881 (Indirect Direct) | View |
2020-09-18 Sale | 2020-09-22 8:10 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 3,035 | $86.87 | $263,636 | 3,969,319 (Indirect Direct) | View |
2020-09-16 Sale | 2020-09-18 4:30 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 8,965 | $86.98 | $779,777 | 3,972,354 (Indirect Direct) | View |
2020-09-14 Sale | 2020-09-16 8:00 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,155 | $84.89 | $98,045 | 3,981,319 (Indirect Direct) | View |
2020-09-10 Sale | 2020-09-11 9:49 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 22,845 | $85.36 | $1,949,996 | 2,152,425 (Indirect Direct) | View |
2020-09-01 Sale | 2020-09-03 9:21 pm | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 60,000 | $92.51 | $5,550,644 | 4,223,064 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-06-09 Option Award | 2022-06-10 5:35 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 12,000 | $0 | 12,000 (Direct) | View |
2021-06-28 Other | 2021-06-30 6:41 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,416,648 | $0 | 1,581,188 (Indirect) | View |
2021-06-28 Conversion | 2021-06-30 5:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 38,309,520 | $0 | 2,097,938 (Indirect) | View |
2021-02-24 Option Award | 2021-06-25 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 3,575,000 | $2 | 9,896,460 (Indirect) | View |
2021-06-23 Option Award | 2021-06-25 5:00 pm | N/A 2031-06-22 | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 47,132 | $0 | 9,896,460 (Direct) | View |
2021-03-11 Option Award | 2021-06-25 5:00 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 2,699,328 | $2.9637 | 9,896,460 (Indirect) | View |
Ownership | 2021-06-23 8:47 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bolzon Bradley J PhD Director 10% Owner | 0 | $0 | 8,739,158 (Indirect) | View |
2021-06-18 Option Award | 2021-06-22 6:12 pm | N/A 2031-06-17 | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
2021-06-10 Option Award | 2021-06-14 5:36 pm | N/A 2031-06-10 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-03-01 Other | 2021-03-03 4:23 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 407,434 | $0 | 1,365,779 (Indirect) | View |
2021-02-19 Other | 2021-02-23 4:40 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 1,416,648 | $0 | 1,628,724 (Indirect) | View |
2020-12-14 Other | 2020-12-16 6:58 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 21,412 | $0 | 5,650,304 (Indirect) | View |
2020-11-27 Other | 2020-12-01 7:13 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 443,053 | $0 | 2,138,983 (Indirect) | View |
2020-11-23 Other | 2020-11-25 4:45 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 792,763 | $0 | 832,615 (Indirect) | View |
2020-11-11 Other | 2020-11-13 7:46 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 989,754 | $0 | 5,972,906 (Indirect) | View |
2020-10-29 Other | 2020-11-02 5:30 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 536,996 | $0 | 2,566,055 (Indirect) | View |
2020-10-07 Other | 2020-10-08 7:14 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 300,522 | $0 | 311,881 (Indirect) | View |
2020-09-22 Other | 2020-09-24 6:09 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 429,596 | $0 | 2,421,474 (Indirect) | View |
2020-09-17 Other | 2020-09-21 7:51 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner | 758,523 | $0 | 784,495 (Indirect) | View |
2020-09-09 Other | 2020-09-11 9:49 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 214,799 | $0 | 2,152,425 (Indirect) | View |
2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 30,000 | $14 | 4,223,064 (Indirect) | View |
2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A 2026-10-18 | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 60,000 | $0 | 4,223,064 (Indirect) | View |
2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $59.31 | 4,223,064 (Indirect) | View |
2020-09-01 Exercise | 2020-09-03 9:21 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director | 15,000 | $13.62 | 4,223,064 (Indirect) | View |